Olmesartan Medoxomil Tablet, Film Coated
Product Images NDC 65862-742

7 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Olmesartan Medoxomil (NDC 65862-742). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Olmesartan Medoxomil Dose Response Placebo-adjusted Reduction In Blood Pressure (mmhg) (Olmesartan Fig1)

Olmesartan Medoxomil Dose Response Placebo-adjusted Reduction In Blood Pressure (mmhg) (Olmesartan Fig1)
A dose-response graph showing the placebo-adjusted reduction in systolic and diastolic blood pressure (mmHg) with increasing doses of olmesartan medoxomil (mg). The chart plots dose on the x-axis and blood pressure reduction on the y-axis, with separate curves for systolic and diastolic blood pressure reductions.*
FDA Label Image

Package Label-principal Display Panel (5 mg (30 Tablet Bottle))

Package Label-principal Display Panel (5 mg (30 Tablet Bottle))
Label for Olmesartan Medoxomil Tablets USP 5 mg by Aurobindo Pharma Limited. The film-coated tablets come in a package of 30 tablets. The label includes dosing information, storage instructions (20° to 25°C), and distributor details for Aurobindo Pharma USA, Inc. The label features a 5 mg strength marking and a barcode on the right side.*
FDA Label Image

Package Label-principal Display Panel (20 mg (30 Tablet Bottle))

Package Label-principal Display Panel (20 mg (30 Tablet Bottle))
Label for Olmesartan Medoxomil Tablets USP 20 mg film-coated tablets. The label states the product is Rx only, distributed by Aurobindo Pharma USA, Inc., and made in India. The package contains 30 tablets with storage instructions at 20° to 25°C. The NDC 65862-742-30 is visible with dosing and manufacturing information.*
FDA Label Image

Package Label-principal Display Panel (20 mg Blister Carton (10 x 10) Unit-dose)

Package Label-principal Display Panel (20 mg Blister Carton (10 x 10) Unit-dose)
Packaging label for Olmesartan Medoxomil Tablets, USP 20 mg film-coated tablets by Aurobindo Pharma Limited. The label shows a unit-dose package containing 100 tablets (10 x 10). The label includes dosage strength, storage instructions, NDC 65862-742-78, and distributor information from Aurobindo Pharma USA, Inc.*
FDA Label Image

Package Label-principal Display Panel (40 mg (30 Tablet Bottle))

Package Label-principal Display Panel (40 mg (30 Tablet Bottle))
Label for Olmesartan Medoxomil Tablets USP 40 mg, film-coated tablets, in a 30-tablet package. Distributed by Aurobindo Pharma USA, Inc., made in India. Storage instructions indicate room temperature (20° to 25°C). NDC 65862-743-30 and barcode included on the label.*
FDA Label Image

Package Label-principal Display Panel (40 mg Blister Carton (10 x 10) Unit-dose)

Package Label-principal Display Panel (40 mg Blister Carton (10 x 10) Unit-dose)
Packaging label for Olmesartan Medoxomil Tablets, USP 40 mg, film-coated tablets. The label indicates the package contains 100 (10 x 10) unit-dose tablets, labeled for prescription use only. It shows the labeler as Aurobindo Pharma Limited, with distribution by Aurobindo Pharma USA, Inc. Storage instructions and dosage advisory are included on the label.*
FDA Label Image

Chemical Structure (Olmesartan Str)

Chemical Structure (Olmesartan Str)
Chemical structure of Olmesartan Medoxomil, the active ingredient in the product. The diagram shows the molecule's atomic connectivity and ring structures consistent with its known chemical formula.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.